DCB-USA LLC has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), Brazil and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are WYETH HOLDINGS LLC, KITHER BIOTECH S R L and AVIXGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Brazil | 2 | |
#3 | United States | 2 | |
#4 | China | 1 | |
#5 | Hong Kong | 1 | |
#6 | Japan | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Environmental technology | |
#6 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Cheng Tian-Lu | 3 |
#2 | Chuang Chih-Hung | 2 |
#3 | Ko Hsiu-Fen | 2 |
#4 | Yang Pan-Chyr | 2 |
#5 | Lu Yun-Chi | 2 |
#6 | Wu Chia-Cheng | 1 |
#7 | Peck Konan | 1 |
#8 | Wang I-Jong | 1 |
#9 | Lai Wei-Yun | 1 |
#10 | Tzeng Cherng-Chyi | 1 |
Publication | Filing date | Title |
---|---|---|
US2016145625A1 | Dnazyme for silencing the expression of EGFR |